Episode Details

Australia stands firm against US tariffs on pharmaceuticals, refusing to yield to pressure from drug giants or Trump administration. The countrys pharmaceutical benefits scheme subsidizes prescriptions, leading to price negotiations with US firms. Health Minister Mark Butler emphasizes the need to resist lobbying efforts targeting such schemes globally. The government is assessing job risks with local businesses and biotech giant CSL secures exemption on blood plasma products, planning a US expansion.

Support the show:
Get a discount at https://solipillow.com/discount/dnn.

Advertise on DNN:
advertise@thednn.ai

This is an automated, high-level news summary based on public reporting.
Report issues to feedback@thednn.ai.

View sources & latest updates:
https://sources.thednn.ai/7b408afbbf52fde6